Carmen Chang's Net Worth
Estimate Recalculated Jun 3, 2025 09:02PM EST
Who is Carmen Chang
Carmen Chang does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include NeueHealth, Inc., Monte Rosa Therapeutics, Inc., Mirum Pharmaceuticals, Inc., Coursera, Inc., GENOCEA BIOSCIENCES, INC., Metacrine, Inc., Savara Inc, Trevi Therapeutics, Inc., Akouos, Inc., Black Diamond Therapeutics, Inc., Arsanis, Inc., Regulus Therapeutics Inc., Marker Therapeutics, Inc., and Korro Bio, Inc..
SEC CIK
Carmen Chang's CIK is 0001746342
Past Insider Trading and Trends
2023 was Carmen Chang's most active year for acquiring shares with 3 total transactions. Carmen Chang's most active month to acquire stocks was the month of April. 2023 was Carmen Chang's most active year for disposing of shares, totalling 1 transactions. Carmen Chang's most active month to dispose stocks was the month of February. 2021 saw Carmen Chang paying a total of $0.00 for 22,985 shares, this is the most they've acquired in one year. In 2023 Carmen Chang cashed out on 1,226 shares for a total of $14,496.59, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
